Form D — Numerion Labs, Inc.
0001736153-25-000001 · filed Mar 14, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $50,000,000
- Reported amount sold
- $44,282,650
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Numerion Labs, Inc.
- CIK
- 1736153
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 250 SUTTER ST. SUITE 650
SAN FRANCISCO, CA 94108 - Phone
- (650) 449-7925
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stephen Worland · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Izhar Wallach · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Robert Mittendorff · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Adam Seabrook · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Linda Maxwell · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Mike Varney · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Yan Zhao · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗